These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 34423572)
1. The safety and efficacy of botulinum toxin A on the treatment of depression. Zhang Q; Wu W; Fan Y; Li Y; Liu J; Xu Y; Jiang C; Tang Z; Cao C; Liu T; Chen LH; Hu H; Luo W Brain Behav; 2021 Sep; 11(9):e2333. PubMed ID: 34423572 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China. Li Y; Zhu T; Shen T; Wu W; Cao J; Sun J; Liu J; Zhou X; Jiang C; Tang Z; Liu T; Chen L; Hu H; Luo W J Affect Disord; 2022 Dec; 318():48-53. PubMed ID: 36063974 [TBL] [Abstract][Full Text] [Related]
3. A novel approach to treating post-stroke depression: administration of Botulinum Toxin A via local facial injection. Feng XY; Shen TT; Wu QC; Wang J; Ni P; Liu J; Zhou XP; Hu H; Luo WF Front Neurol; 2024; 15():1372547. PubMed ID: 38957350 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache. Wang Y; Yang X; Ji X; Liu M; Zhou C Psychopharmacology (Berl); 2023 Oct; 240(10):2061-2070. PubMed ID: 37481677 [TBL] [Abstract][Full Text] [Related]
5. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder. Munizza C; Olivieri L; Di Loreto G; Dionisio P Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574 [TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of two different doses of botulinum toxin A for the treatment of mild to moderate depression. Shu H; Shen T; Deng W; Cao J; Xu Y; Liu J; Zhou X; Luo WF J Affect Disord; 2024 Apr; 350():824-830. PubMed ID: 38246284 [TBL] [Abstract][Full Text] [Related]
7. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related]
8. Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1. Komorousova J; Beran J; Rusavy Z; Jankovec Z Neuro Endocrinol Lett; 2010; 31(6):801-6. PubMed ID: 21196929 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial. Pappert EJ; Germanson T; Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247 [TBL] [Abstract][Full Text] [Related]
11. Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial. Wang L; Zhong Z; Hu J; Rong X; Liu J; Xiao S; Liu Z BMC Psychiatry; 2015 Apr; 15():84. PubMed ID: 25879863 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study. Lin CH; Lin SH; Jang FL J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699 [TBL] [Abstract][Full Text] [Related]
13. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411 [TBL] [Abstract][Full Text] [Related]
14. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. He Y; Zheng Y; Xu C; Yang H; Wang Z; Zhou L; Wan Y; Zheng D; Zhu J Clin Respir J; 2016 May; 10(3):318-25. PubMed ID: 25308771 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older. Finkel SI; Richter EM; Clary CM Int Psychogeriatr; 1999 Mar; 11(1):85-99. PubMed ID: 10189602 [TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of sertraline in maintenance hemodialysis patients with depression: A randomized controlled study. Zhang S; Xu Y; Xia Y J Affect Disord; 2024 May; 352():60-66. PubMed ID: 38336164 [TBL] [Abstract][Full Text] [Related]
17. Suicidal thinking and behavior during treatment with sertraline in late-life depression. Nelson JC; Delucchi K; Schneider L Am J Geriatr Psychiatry; 2007 Jul; 15(7):573-80. PubMed ID: 17586782 [TBL] [Abstract][Full Text] [Related]
18. Jiawei Xiaoyao capsule treatment for mild to moderate major depression with anxiety symptoms: a randomized, double-blind, double-dummy, controlled, multicenter, parallel-treatment trial. Su R; Fan J; Li T; Cao X; Zhou J; Han Z; Ma Y J Tradit Chin Med; 2019 Jun; 39(3):410-417. PubMed ID: 32186013 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C; Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565 [TBL] [Abstract][Full Text] [Related]
20. The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial. Schweizer E; Rynn M; Mandos LA; Demartinis N; García-España F; Rickels K Int Clin Psychopharmacol; 2001 May; 16(3):137-43. PubMed ID: 11354235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]